Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| CGM & insulin pump management · Nevada | CGM & insulin pump management · California | |
|---|---|---|
| Surgeons, 2024 | 41 | 513 |
| Medicare fee-for-service cases | 5,936 | 68,597 |
| Growth since 2019 (Medicare FFS) | +7.7%/yr | +18%/yr |
| Forecast cases (Medicare FFS) | 10,900 in 2030 | 127,400 in 2030 |
| Forecast growth | +11%/yr to 2030 | +11%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 20.3 | 20.1 |
| Medicare Advantage share | 56% | 56% |
| Out of hospital | 95% (−5 pts since 2019) | 91% (−4 pts since 2019) |
| Cases per surgeon | 145 | 134 |
| Top 10 surgeons' share | 61% | 11% |
| Surgeons growing | 16 | 178 |
| New since the base year | 14 | 212 |
| Likely to stop billing it | 1 by 2026 | 36 by 2026 |
| Forecast miss, 1 year (procedure) | 3% | 3% |
| Company payments per surgeon | $2,317 | $2,060 |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.